Dietary Guidelines for Patients with Decompensated Cirrhosis

For individuals living with decompensated cirrhosis—a stage where the liver can no longer adequately perform its essential functions—dietary management is a critical component of clinical care. Unlike compensated cirrhosis, where patients may remain asymptomatic for years, decompensation signals the onset of overt complications such as ascites, hepatic encephalopathy, variceal bleeding, or jaundice. At this stage, nutritional interventions must be carefully tailored to mitigate disease progression, prevent acute decompensation events, and support overall metabolic stability.

Protein intake requires individualized assessment: while excessive protein may exacerbate hepatic encephalopathy in susceptible patients, insufficient intake accelerates muscle wasting and sarcopenia—both strongly associated with increased mortality. Current guidelines recommend 1.2–1.5 g/kg/day of high-biological-value protein, distributed evenly across meals and supplemented with nighttime snacks to counteract catabolism during fasting periods.

Sodium restriction remains foundational—typically limited to ≤2,000 mg per day—to reduce fluid retention and slow ascites progression. This necessitates avoiding processed foods, canned soups, condiments, and restaurant meals, which often contain hidden sodium. Patients should also monitor daily weight; an increase of ≥2 kg over three days warrants prompt clinical evaluation.

Caloric adequacy is equally vital. Many patients with decompensated cirrhosis experience hypermetabolism and malnutrition despite normal or elevated BMI. A target of 35–40 kcal/kg/day is advised, with carbohydrates providing the primary energy source. However, fructose-rich foods and added sugars should be minimized due to their potential contribution to hepatic steatosis and insulin resistance.

Alcohol must be strictly avoided—abstinence is non-negotiable, as even minimal intake accelerates hepatocyte injury and increases risk of further decompensation. Additionally, vitamin supplementation—particularly fat-soluble vitamins (A, D, E, K) and thiamine—should be guided by laboratory assessment, given frequent deficiencies stemming from cholestasis, poor absorption, or dietary insufficiency.

Finally, all dietary modifications should be implemented under the supervision of a hepatology-trained dietitian and integrated into a multidisciplinary care plan that includes pharmacologic therapy, surveillance for hepatocellular carcinoma, and timely referral for liver transplantation evaluation when appropriate.